Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is pleased to announce that it has received the ...

For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research ...

Salvage focal therapy and radical prostatectomy are both effective in treating localized radiorecurrent prostate cancer, a cohort study suggested. There were no statistically significant differences ...

Urinary changes like frequent urination, weak stream, and nocturia are common in men over 50, often due to an enlarged ...

Lt. Col. Ronald “RJ” Caras, a urologist at Madigan Army Medical Center, has been named the American Urological Association’s ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ('Profound” or the 'Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, will ...

Today, many men must choose between life-altering prostate removal or careful long-term monitoring. The EU-funded ROBIOSPY ...

Wayne Lewis, 71, a local member of the Wagga Wagga Prostate Cancer Support Group, doesn't want men to be put off being tested for prostate cancer ...

After missing most of the 2025 season while battling prostate cancer, Terrell Williams will move to a new role on the ...

A novel, cooled laser focal therapy (cLFT) exhibits high treatment success for localized prostate cancer (PCa), according to a study published online Jan. 28 in ...

New research shows that the types of fats we eat, like those in cooking oils, might influence the rate at which cancer cells multiply.